» Articles » PMID: 16985773

Seminal Vesicle Invasion by Prostate Cancer: Prognostic Significance and Therapeutic Implications

Overview
Journal Rev Urol
Date 2006 Sep 21
PMID 16985773
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

When the pathologist's report following radical prostatectomy describes seminal vesicle invasion (SVI), generally the outlook for the patient is poor. But are we all on the same page of the same book when we talk about SVI? Does it mean muscular wall invasion? Does it include the ejaculatory duct? Getting a clear definition can have far-reaching clinical implications for patient prognosis and treatment.

Citing Articles

Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis.

Ali A, Elumalai T, Venkatesulu B, Hekman L, Mistry H, Sachdeva A BMJ Oncol. 2025; 3(1):e000193.

PMID: 39886173 PMC: 11234997. DOI: 10.1136/bmjonc-2023-000193.


Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [Ga]Ga-PSMA-11 PET/MRI.

Spielvogel C, Ning J, Kluge K, Haberl D, Wasinger G, Yu J Insights Imaging. 2024; 15(1):299.

PMID: 39666257 PMC: 11638435. DOI: 10.1186/s13244-024-01876-5.


Salvage vesiculectomy for local prostate cancer recurrence: surgical technique and early post-operative outcomes.

Giesen A, Van den Broeck T, Develtere D, Raskin Y, Wymer K, Eden C World J Urol. 2024; 42(1):81.

PMID: 38358521 DOI: 10.1007/s00345-024-04771-2.


Take metabolic heterogeneity into consideration when applying dietary interventions to cancer therapy: A review.

Ni C, Li J Heliyon. 2024; 9(12):e22814.

PMID: 38213585 PMC: 10782175. DOI: 10.1016/j.heliyon.2023.e22814.


Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target.

Ferrari M, Jimenez-Uribe A, Wang L, Hoeppner L, Murugan P, Hahm E Oncogene. 2023; 43(7):484-494.

PMID: 38135694 PMC: 10857939. DOI: 10.1038/s41388-023-02925-x.


References
1.
Salomao D, Graham S, Bostwick D . Microvascular invasion in prostate cancer correlates with pathologic stage. Arch Pathol Lab Med. 1995; 119(11):1050-4. View

2.
McNeal J, Yemoto C . Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol. 1996; 20(7):802-14. DOI: 10.1097/00000478-199607000-00003. View

3.
Cadeddu J, Partin A, DeWeese T, Walsh P . Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol. 1997; 159(1):173-7; discussion 177-8. DOI: 10.1016/s0022-5347(01)64047-3. View

4.
Tefilli M, Gheiler E, Tiguert R, Banerjee M, Sakr W, Grignon D . Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer. J Urol. 1998; 160(3 Pt 1):802-6. DOI: 10.1016/S0022-5347(01)62791-5. View

5.
Byar D, Mostofi F . Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer. 1972; 30(1):5-13. DOI: 10.1002/1097-0142(197207)30:1<5::aid-cncr2820300103>3.0.co;2-s. View